@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QXR112BW-4
  mesh:allowableQualifier jvr:-XV06LPML-W, jvr:-H7K65Q8S-Z, jvr:-N2WP45CN-V, jvr:-Z9TSGBXH-4, jvr:-D0F21513-5, jvr:-L6C0XPHT-4, jvr:-S0CS1X5R-5, jvr:-WZF2ZR3L-B, jvr:-G7KXQWSR-5, jvr:-NFTHND7Q-8, jvr:-THHNVC7V-3, jvr:-Q3979798-W, jvr:-TJHVZCRZ-0, jvr:-HQRFT0C6-B, jvr:-W6SQV79N-S, jvr:-WK5F724J-1, jvr:-CB30NGKB-3, jvr:-R3QWLHRG-V, jvr:-NB0XHT3S-N, jvr:-SBNWSM1T-R, jvr:-NKM836P1-M, jvr:-R0ZCQ8X6-J, jvr:-CJXMKG5Q-F, jvr:-G30ZJ446-J, jvr:-M63HSDM7-1, jvr:-T9HQD7ST-J, jvr:-T2TS0S41-N, jvr:-FWD2BGQ0-9, jvr:-BT300B3G-Q ;
  skos:hiddenLabel "alpha1-Macroglobuline"@fr, "Protéine alpha1 de la phase aigüe"@fr, "alpha-1-Protéine de la phase aigüe"@fr, "alpha 1-Macroglobulin"@en, "Slow alpha 2-Globulin"@en, "alpha 2-Acute Phase Globulins"@en, "alpha-1-Globuline de la phase aiguë"@fr, "alpha-2-Globulines de la phase aiguë"@fr, "alpha-1-Globuline de la phase aigüe"@fr, "Globulines alpha2 de la phase aigüe"@fr, "alpha-Macrofoetoprotéine"@fr, "Globulines alpha-2 lentes"@fr, "Protéine alpha-1 de la phase aigüe"@fr, "Acute-Phase alpha 1-Protein"@en, "Globulines alpha2 lentes"@fr, "alpha-2-Globulines de la phase aigüe"@fr, "alpha2-Globulines de la phase aigüe"@fr, "alpha 1-Acute Phase Globulin"@en, "alpha 1-Acute Phase Protein"@en, "Macroglobuline alpha-1"@fr, "alpha-2-Macroglobulines lentes"@fr, "Globuline alpha-1 de la phase aigüe"@fr, "Macroglobuline alpha1"@fr, "alpha-1-Protéine de la phase aiguë"@fr, "alpha1-Protéine de la phase aigüe"@fr, "Macroglobulines alpha-2 lentes"@fr, "Globulines alpha-2 de la phase aigüe"@fr, "Macrofoetoprotéine alpha"@fr, "alpha 2-Acute Phase Globulin"@en, "Slow alpha 2-Macroglobulins"@en, "Macroglobulines alpha2 lentes"@fr, "alpha-2-Globulines lentes"@fr, "alpha2-Globulines lentes"@fr, "alpha-1-Macroglobuline"@fr, "Globuline alpha1 de la phase aigüe"@fr, "alpha-Macrofetoprotein"@en, "alpha1-Globuline de la phase aigüe"@fr, "alpha2-Macroglobulines lentes"@fr ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D000511> ;
  skos:prefLabel "alpha-Macroglobulines"@fr, "alpha-Macroglobulins"@en ;
  a skos:Concept, mesh:Descriptor ;
  skos:broader jvr:-DT1P6TLJ-F, jvr:-VDTM9G66-0, jvr:-FG7W42R9-H ;
  dc:created "1975-07-18"^^xsd:date ;
  skos:altLabel "Macroglobulines alpha"@fr, "alpha-Macrofetoproteins"@en, "45S RNP"@en ;
  skos:definition "Glycoproteins with a molecular weight of approximately 620,000 to 680,000. Precipitation by electrophoresis is in the alpha region. They include alpha 1-macroglobulins and alpha 2-macroglobulins. These proteins exhibit trypsin-, chymotrypsin-, thrombin-, and plasmin-binding activity and function as hormonal transporters."@en ;
  skos:inScheme jvr: ;
  skos:narrower jvr:-QP2BMWD1-9 ;
  dc:modified "2017-06-29"^^xsd:date ;
  dc:established "1976-01-01"^^xsd:date .

jvr:-FG7W42R9-H
  skos:prefLabel "Acute-Phase Proteins"@en, "Protéine de la phase aigüe"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-QXR112BW-4 .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G7KXQWSR-5
  skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z9TSGBXH-4
  skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QP2BMWD1-9
  skos:prefLabel "Pregnancy-Associated alpha 2-Macroglobulins"@en, "alpha 2-Macroglobulines associées à la grossesse"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-QXR112BW-4 .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T2TS0S41-N
  skos:prefLabel "ultrastructure (Qualifier)"@en, "ultrastructure (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CJXMKG5Q-F
  skos:prefLabel "deficiency (Qualifier)"@en, "déficit (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-DT1P6TLJ-F
  skos:prefLabel "alpha-Globulines"@fr, "Alpha-Globulins"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-QXR112BW-4 .

jvr:-N2WP45CN-V
  skos:prefLabel "drug effects (Qualifier)"@en, "effets des médicaments et des substances chimiques (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VDTM9G66-0
  skos:prefLabel "Macroglobulines"@fr, "Macroglobulins"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-QXR112BW-4 .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WZF2ZR3L-B
  skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

